Harlequin baby treated with etretinate
Related Experiment Videos
Pediatric Dermatology
|September 1, 1989
Insights
A baby with harlequin fetus syndrome survived and improved spontaneously. Treatment with etretinate further resolved symptoms, with the child now over two years old.
Area of Science:
- Dermatology
- Genetics
- Pediatrics
Background:
- Harlequin fetus syndrome is a severe, rare congenital skin disorder.
- It is characterized by thick, plate-like scales and fissured skin.
- Infants typically have a poor prognosis and high mortality rate.
Observation:
- A neonate diagnosed with harlequin fetus syndrome exhibited unexpected spontaneous improvement within the first six weeks of life.
- This early improvement suggested potential for better outcomes than typically observed.
Findings:
- Institution of etretinate therapy at six weeks of age led to significant further resolution of the harlequin fetus symptoms.
- The child demonstrated sustained improvement and is currently over two years old, indicating long-term benefits of treatment.
Implications:
- This case highlights the potential for survival and significant improvement in harlequin fetus syndrome.
- Early intervention with systemic retinoids like etretinate may be a viable therapeutic strategy.
- Further research is warranted to explore optimal treatment protocols and long-term management for this rare condition.
Abstract:
A child born with the harlequin fetus abnormality survived and showed a surprising degree of spontaneous improvement in the first six weeks of life. At this age etretinate was instituted, producing considerable further resolution. The child is now over 2 years old.